查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566179

軟骨修復市場規模、佔有率、成長分析、按治療方式、按應用、按應用場所、按地區 - 行業預測，2024-2031 年

Cartilage Repair Market Size, Share, Growth Analysis, By Treatment Modality, By Application, By Application site, By Region - Industry Forecast 2024-2031
出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2022年全球軟骨修復市場規模約為10億美元，預計將從2023年的12.5億美元達到2031年的43.8億美元，預測期內（2024-2031年）的複合年成長率為17%。

由於肌肉骨骼疾病盛行率的上升、關節健康意識的增強以及再生醫學的進步，全球軟骨修復市場正在經歷顯著成長。軟骨損傷通常是由創傷、過度使用和骨關節炎等退化性疾病引起的，這增加了對有效修復解決方案的需求。容易遭受軟骨損傷的老年人口不斷增加，以及各年齡層運動相關損傷的增加，進一步推動了市場的發展。幾種創新技術已成為軟骨修復的可行選擇，包括自體軟骨細胞移植術（ACI）、微骨折、自體骨軟骨移植和合成支架的開發。該市場的主要參與者不斷投資於研發，以開發侵入性較小且持久的治療方法。此外，醫療保健提供者正在關注微創手術，以縮短復原時間並改善患者的治療效果。政府和醫療機構正在透過報銷政策和研究計劃資助來促進再生療法的採用。儘管成長潛力巨大，但該市場面臨治療成本高、監管核准嚴格和程序複雜等挑戰。高傷害復發率和有限的熟練專業人員進一步限制了市場。然而，隨著3D生物列印和幹細胞治療等技術進步，以及個人化醫療的日益普及，軟骨修復市場有望在未來幾年強勁成長。

目錄

介紹

  • 研究目的
  • 定義
  • 市場範圍

調查方法

  • 資訊採購
  • 二手資料來源和主要資料來源
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 市場概況展望
  • 供需趨勢分析
  • 按細分市場的機會分析

市場動態及展望

  • 市場動態
    • 促進因素
    • 機會
    • 抑制因素
    • 任務
  • 波特的分析

主要市場考察

  • 關鍵成功因素
  • 競爭程度
  • 主要投資機會
  • 市場生態系統
  • 供應鏈分析
  • 監管環境
  • 專利分析
  • 技術分析

軟骨修復市場：依治療方式分類

  • 市場概況
  • 基於細胞的軟骨修復/軟骨再生
    • 軟骨細胞移植
    • 生長因子
    • 幹細胞
  • 去細胞軟骨修復/軟骨再生
    • 組織支架
    • 無細胞複合材料

軟骨修復市場：按應用部位

  • 市場概況
  • 膝蓋
  • 髖關節
  • 腳踝和腳
  • 其他應用部分

軟骨修復市場：依應用分類

  • 市場概況
  • 透明軟骨
  • 纖維軟骨

軟骨修復市場規模：按地區

  • 市場概況
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲 (MEA)
    • 海灣合作理事會國家
    • 南非
    • 其他中東/非洲地區

競爭格局

  • 前5名企業對比
  • 主要企業市場定位（2023年）
  • 主要市場參與者所採取的策略
  • 近期市集活動
  • 主要企業市場佔有率（2023年）

主要企業簡介

  • DePuy Synthes（Johnson & Johnson）
  • Zimmer Biomet Holdings Inc.
  • Smith & Nephew plc
  • Vericel Corporation
  • Osiris Therapeutics Inc.
  • Histogenics Corporation
  • Anika Therapeutics Inc.
  • Arthrex Inc.
  • B. Braun Melsungen AG
  • Stryker Corporation
  • CONMED Corporation
  • Orthocell Limited
  • RTI Surgical Holdings Inc.
  • MEDIPOST Co. Ltd.
  • CellGenix GmbH
  • Tissue Regenix Group plc
  • CollPlant Biotechnologies Ltd.
  • ISTO Technologies Inc.
  • MTF Biologics
  • CartiHeal Ltd.
簡介目錄
Product Code: SQMIG35D2072

Global Cartilage Repair Market size was valued at around 1 billion in 2022 and is expected to rise from USD 1.25 billion in 2023 to reach a value of USD 4.38 billion by 2031, at a CAGR of 17% over the forecast period (2024-2031).

The global cartilage repair market has experienced substantial growth due to the rising prevalence of musculoskeletal diseases, increasing awareness about joint health, and advancements in regenerative medicine. Cartilage damage, often caused by trauma, overuse, or degenerative conditions like osteoarthritis, has led to a growing demand for effective repair solutions. The market is further fueled by the expanding elderly population, which is more prone to cartilage injuries, and the rise in sports-related injuries across all age groups. Several innovative techniques, such as autologous chondrocyte implantation (ACI), microfracture, osteochondral autografts, and the development of synthetic scaffolds, have emerged as viable options for cartilage restoration. Key players in this market are continuously investing in research and development to create less invasive and more durable treatments. Additionally, healthcare providers are focusing on minimally invasive surgeries that reduce recovery time and enhance patient outcomes. Governments and healthcare organizations are promoting the adoption of regenerative therapies through reimbursement policies and funding for research initiatives. Despite the significant growth potential, the market faces challenges such as high treatment costs, stringent regulatory approvals, and the complexity of cartilage repair procedures. The high recurrence rate of injuries and the limited availability of skilled professionals further constrain the market. However, with technological advancements, such as 3D bioprinting and stem cell therapy, and the increasing popularity of personalized medicine, the cartilage repair market is poised for robust growth in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cartilage Repair Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cartilage Repair Market Segmental Analysis

Global Cartilage Repair Market is segmented by Treatment Modality, Application, Application Site, and region. Based on Treatment Modality, the market is segmented into Cell-based (Chondrocyte Transplantation, Stem Cells, Growth Factors), Non-cell-based (Tissue Scaffolds, Cell-free Composites). Based on Application, the market is segmented into Knee, Hip, Ankle and Foot, and Other Application Sites. Based on Application Site, the market is segmented into Hyaline Cartilage, Fibrocartilage. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Cartilage Repair Market

One of the key drivers propelling the global cartilage repair market is the rapid advancement in regenerative medicine, particularly in cell-based therapies and tissue engineering. Innovations such as autologous chondrocyte implantation (ACI), stem cell therapies, and gene editing have significantly improved the efficacy of cartilage repair treatments. These technologies focus on regenerating cartilage tissue by using the body's own cells or bioengineered tissues, reducing the chances of rejection and improving long-term outcomes. Furthermore, the development of biomaterials and scaffolds that mimic the natural cartilage environment has enhanced the ability to restore joint function and prevent further damage. With the integration of 3D bioprinting and tissue scaffolding, researchers are now able to precisely reconstruct cartilage structures, paving the way for more personalized and effective treatments. The increasing collaboration between biotechnology firms, research institutes, and healthcare providers has also accelerated clinical trials, resulting in faster commercialization of advanced cartilage repair therapies.

Restraints in the Global Cartilage Repair Market

Despite the advancements in cartilage repair, the high cost of procedures remains a significant restraint for the market. Treatments such as autologous chondrocyte implantation (ACI) and stem cell therapies involve complex processes, including the extraction, cultivation, and implantation of cells, which drive up the overall costs. Additionally, the need for specialized equipment, skilled surgeons, and postoperative care contributes to the high expenses associated with these treatments. For instance, ACI, one of the most effective cartilage repair methods, can cost tens of thousands of dollars, making it inaccessible to many patients, especially in low- and middle-income regions. Moreover, in several countries, these procedures are not fully covered by insurance, placing a significant financial burden on patients. This cost factor not only limits the market penetration of advanced cartilage repair treatments but also encourages patients to opt for less effective, conservative treatment options like pain management and physical therapy.

Market Trends of the Global Cartilage Repair Market

A notable trend in the global cartilage repair market is the growing demand for minimally invasive techniques. Patients and healthcare providers are increasingly favoring procedures that involve smaller incisions, less tissue damage, and shorter recovery periods. Minimally invasive surgeries, such as arthroscopic microfracture and osteochondral autograft transfer, are gaining traction due to their ability to repair cartilage while minimizing the risks associated with traditional open surgeries. These procedures not only lead to quicker rehabilitation but also reduce the likelihood of complications such as infection or blood loss. Furthermore, technological advancements, including the use of robotics and image-guided systems, have improved the precision and success rates of these surgeries. As patient preferences shift toward less invasive options, medical device manufacturers are developing new tools and instruments to facilitate these procedures. This trend is expected to drive further innovations in cartilage repair, leading to improved patient outcomes and expanding the market in the coming years.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factor
  • Degree of Competition
  • Top Investment Pockets
  • Ecosystem of the Market
  • Supply Chain Analysis
  • Regulatory Landscape
  • Patent Analysis
  • Technology Analysis

Cartilage Repair Market, By Treatment Modality

  • Market Overview
  • Cell-Based Cartilage Repair/Cartilage Regeneration
    • Chondrocyte Transplantation
    • Growth Factors
    • Stem Cells
  • Non-Cell-Based Cartilage Repair/Cartilage Regeneration
    • Tissue Scaffolds
    • Cell-Free Composites

Cartilage Repair Market, By Application Site

  • Market Overview
  • Knee
  • Hip
  • Ankle & Foot
  • Other Application Sites

Cartilage Repair Market, By Application

  • Market Overview
  • Hyaline Cartilage
  • Fibrocartilage

Cartilage Repair Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • DePuy Synthes (Johnson & Johnson)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zimmer Biomet Holdings Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smith & Nephew plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vericel Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Osiris Therapeutics Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Histogenics Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Anika Therapeutics Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Arthrex Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CONMED Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Orthocell Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • RTI Surgical Holdings Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MEDIPOST Co. Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CellGenix GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tissue Regenix Group plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CollPlant Biotechnologies Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ISTO Technologies Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MTF Biologics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CartiHeal Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments